Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.National Stem Cell Holding has announced that its wholly owned subsidiary Proteoderm, will introduce the company's first commercial line of cosmoceuticals, which will be sold through medical sales representatives for use by dermatologists, plastic surgeons and other licensed health care professionals.
Subscribe to our email newsletter
Proteoderm has created an anti-aging and anti-wrinkle product line that is said to enhance the skin’s firmness and elasticity and promotes the skin’s natural moisture production activity.
Unlike the array of products on the market that reduce the appearance of wrinkles by artificial moisturizing and plumping, Proteoderm’s products are said to be the first to provide Matrix NC 138 to the skin surface.
Proteoderm’s cosmoceutical kits will contain day and night creams and an under-eye serum containing the patented Matrix NC 138 as well as an exfoliant and a cleanser.
Michael Cohen, CEO of National Stem Cell Holding, said: “We are very excited to commercialize Proteoderm’s first line of cosmoceuticals. We look forward to enhancing shareholders’s value as we introduce our unique product. This is a turning point in the maturation of our company.”